| First Author | Tribolet L | Year | 2023 |
| Journal | Immunobiology | Volume | 228 |
| Issue | 3 | Pages | 152380 |
| PubMed ID | 37031606 | Mgi Jnum | J:338376 |
| Mgi Id | MGI:7510290 | Doi | 10.1016/j.imbio.2023.152380 |
| Citation | Tribolet L, et al. (2023) Identification of a novel role for the immunomodulator ILRUN in the development of several T cell subsets in mice. Immunobiology 228(3):152380 |
| abstractText | Inflammation and lipid regulator with UBA-like and NBR1-like domains (ILRUN) is a protein-encoding gene associated with innate immune signaling, lipid metabolism and cancer. In the context of innate immunity, ILRUN inhibits IRF3-mediated transcription of antimicrobial and proinflammatory cytokines by inducing degradation of the transcriptional coactivators CBP and p300. There remains a paucity of information, however, regarding the innate immune roles of ILRUN beyond in vitro analyses. To address this, we utilize a knockout mouse model to investigate the effect of ILRUN on cytokine expression in splenocytes and on the development of immune cell populations in the spleen and thymus. We show elevated production of tumor necrosis factor and interleukin-6 cytokines in ILRUN-deficient splenocytes following stimulation with the innate immune ligands polyinosinic:polycytidylic acid or lipopolysaccharide. Differences were also observed in the populations of several T cell subsets, including regulatory, mucosal-associated invariant and natural killer. These data identify novel functions for ILRUN in the development of certain immune cell populations and support previous in vitro findings that ILRUN negatively regulates the synthesis of pathogen-stimulated cytokines. This establishes the ILRUN knockout mouse model as a valuable resource for further study of the functions of ILRUN in health and disease. |
